Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.

de Heer EC. et al, (2023), J Exp Clin Cancer Res, 42

p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer

Miller P. et al, (2023), Cell Death & Differentiation

Oxali(IV)Fluors: Fluorescence Responsive Oxaliplatin(IV) Complexes Identify a Hypoxia-Dependent Reduction in Can-cer Cells

Boulet M. et al, (2023), Journal of the American Chemical Society

Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients.

Zhang B. et al, (2023), BMC Cancer, 23

A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment

Pelizzari-Raymundo D. et al, (2023), iScience, 26

Acid-adapted cancer cells alkalinize their cytoplasm by degrading the acid-loading membrane transporter Anion Exchanger 2 (SLC4A2)

MICHL J. et al, (2023), Cell Reports

Multi-trait genome-wide association study identifies a novel endometrial cancer risk locus that associates with testosterone levels

Wang X. et al, (2023), iScience, 26

MHC class II antigen presentation by intestinal epithelial cells fine-tunes bacteria-reactive CD4 T cell responses.

Heuberger CE. et al, (2023), Mucosal Immunol

Treatment Delays in Children and Young Adults with Lymphoma: report from an East Africa Lymphoma Cohort Study

Mawalla WF. et al, (2023), Blood Advances

Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.

Clift AK. et al, (2023), BMJ, 381

Triple modality image reconstruction of PET data using SPECT, PET, CT information increases lesion uptake in images of patients treated with radioembolization with [Formula: see text] micro-spheres.

Deidda D. et al, (2023), EJNMMI Phys, 10

The Newfoundland and Labrador mosaic founder population descends from an Irish and British diaspora from 300 years ago.

Gilbert E. et al, (2023), Commun Biol, 6

Re: Fifteen-year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

Sharma AD. et al, (2023), Eur Urol

Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors.

Luke JJ. et al, (2023), Br J Cancer

Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulatory and cytotoxic T cells.

Jainarayanan A. et al, (2023), iScience, 26

The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research.

Fittall M. et al, (2023), Br J Cancer

Data from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models

Rodriguez-Berriguete G. et al, (2023)

Supplementary Figure S1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models

Rodriguez-Berriguete G. et al, (2023)

Supplementary Figure S1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models

Rodriguez-Berriguete G. et al, (2023)

Supplementary Figure S2 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models

Rodriguez-Berriguete G. et al, (2023)

Load More

1
2
3
4
5
6
7
...
»